Mental Health in Austrian Teenagers (MHAT) (MHAT)

March 5, 2019 updated by: Dr. Andreas Karwautz, Medical University of Vienna

The Mental Health in Austrian Teenagers (MHAT) - Study: First Epidemiological Survey

The purpose of the Mental Health in Austrian Teenagers (MHAT) - Study is to collect the first epidemiological data on mental health and psychiatric disorders in a representative sample of Austrian adolescents between 10 and 18 years.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Knowing about the prevalence of psychiatric disorders and related risk and protective factors is essential for the development of prevention programs and therapeutic approaches. Up to now, no epidemiological data on prevalence rates of psychiatric disorders and related risk and protective factors based on a representative sample is available for Austrian adolescents.

The aim of the study is to present rates of behavioral, emotional and social problems as well as prevalence rates of mental disorders. Furthermore the investigators want to examine risk factors, protective factors and quality of life in a large sample of adolescents aged 10 to 18 years. A two step design is chosen for this purpose to obtain diagnoses based on the Diagnostic and Statistical Manual of the American Psychiatric Association, Version 5 (DSM-5):

  1. Phase 1 (screening) is a screening for emotional, behavioral and social problems as well as social and demographic correlates, risk and protective factors and quality of life.
  2. Phase 2 (interviews) includes structured diagnostic interviews to assess psychiatric diagnoses according to DSM-5 criteria with adolescents above a predefined cut-off score in the screening, and a random sample of adolescents scoring below the cut-off.

Study Type

Observational

Enrollment (Actual)

4000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Austria
      • Vienna, Austria, 1090
        • Medical University of Vienna, Dep. of Child and Adolescent Psychiatry

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

10 years to 18 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

general population

Description

Inclusion Criteria:

  • adolescents aged 10-18

Exclusion Criteria:

  • no written informed consent possible due to intelligence or no willingness by parents to include minor

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Cross-Sectional

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
General population
recruited from schools and other institutions like job-centers or child and adolescent psychiatries
Other: 2-phase epidemiological study (screening, interviews)
first phase is the screening phase, second phase is the interview phase

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
psychiatric problems (diagnoses based on the Diagnostic and Statistical Manual of the American Psychiatric Association, Version 5 (DSM-5)
Time Frame: 12 months
Screening and interview
12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
rates of behavioral, emotional and social problems (representation of data collected at interview)
Time Frame: 12 months
YSR (Youth Self Report) questionnaire
12 months
psychiatric disorder related risks and protective factors (representation of data collected at interviews)
Time Frame: 12 months
Kinder-DIPS (Diagnostisches Interview psychischer Störungen) interview
12 months
quality of life (total score, self-perception, parent relation & home life, social support & peers, school environment and bullying)
Time Frame: 12 months
KIDSCREEN (Kidscreen) questionnaire
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Medical University of Vienna

Collaborators

Pharmig - Gesundheitsziele aus dem Rahmen-Pharmavertrag
Ludwig Boltzmann Institute Health Promotion Research

Investigators

  • Study Director: Andreas Karwautz, MD, Prof, Medical University Vienna
  • Study Director: Wolfgang Dür, Phd, Prof, Ludwig Boltzmann Institute LBIHPR

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2013

Primary Completion (Actual)

April 1, 2015

Study Completion (Actual)

April 1, 2015

Study Registration Dates

First Submitted

July 21, 2014

First Submitted That Met QC Criteria

September 28, 2017

First Posted (Actual)

October 4, 2017

Study Record Updates

Last Update Posted (Actual)

March 7, 2019

Last Update Submitted That Met QC Criteria

March 5, 2019

Last Verified

March 1, 2019

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • FA765A0303

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mental Disorders

Clinical Trials on 2-phase epidemiological study (screening, interviews)

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in New Zealand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe